Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Edwards Lifesciences Corp. (NYSE:EW)

Analysis of Long-term (Investment) Activity Ratios
Quarterly Data

Beginner level

Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.

Long-term Activity Ratios (Summary)

Edwards Lifesciences Corp., long-term (investment) activity ratios (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Net fixed asset turnover 3.14 3.42 3.61 4.07 4.10 4.26 4.26 4.28 4.29 4.40 4.61 4.84 5.05 5.10 5.15 5.35 5.11 — — —
Net fixed asset turnover (including operating lease, right-of-use asset) 2.95 3.20 3.38 3.81 3.81 3.97 3.96 3.97 4.29 4.40 4.61 4.84 5.05 5.10 5.15 5.35 5.11 — — —
Total asset turnover 0.61 0.64 0.67 0.74 0.67 0.70 0.71 0.70 0.70 0.61 0.62 0.59 0.60 0.60 0.63 0.66 0.66 — — —
Equity turnover 0.96 1.04 1.13 1.15 1.05 1.09 1.13 1.11 1.19 1.08 1.12 1.06 1.16 1.05 1.10 1.15 1.13 — — —

Based on: 10-K (filing date: 2021-02-12), 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Edwards Lifesciences Corp.’s net fixed asset turnover ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Edwards Lifesciences Corp.’s net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Edwards Lifesciences Corp.’s total asset turnover ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Edwards Lifesciences Corp.’s equity turnover ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Net Fixed Asset Turnover

Edwards Lifesciences Corp., net fixed asset turnover calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Selected Financial Data (US$ in thousands)
Net sales 1,191,700  1,140,900  925,000  1,128,700  1,174,100  1,094,000  1,086,900  993,000  977,700  906,600  943,700  894,800  888,500  821,500  841,800  883,500  767,700  739,400  759,300  697,300 
Property, plant, and equipment, net 1,395,200  1,276,300  1,195,600  1,100,600  1,060,300  973,600  931,100  892,200  867,500  826,100  770,200  711,600  679,700  649,600  627,900  588,800  580,000  543,700  516,200  497,300 
Long-term Activity Ratio
Net fixed asset turnover1 3.14 3.42 3.61 4.07 4.10 4.26 4.26 4.28 4.29 4.40 4.61 4.84 5.05 5.10 5.15 5.35 5.11 — — —
Benchmarks
Net Fixed Asset Turnover, Competitors2
Becton, Dickinson & Co. 2.89 2.90 3.07 3.00 3.06 3.08 3.11 3.18 2.97 2.77 2.50 2.33 2.61 2.76 3.13 3.25 3.20 3.23 3.24 2.83
Boston Scientific Corp. — 4.90 4.89 5.14 5.16 5.35 5.54 5.58 5.51 5.59 5.54 5.45 5.33 5.26 5.28 5.19 5.14 5.45 5.35 5.24
Danaher Corp. 6.83 6.68 6.35 6.03 7.78 7.31 7.43 7.75 7.92 7.97 7.74 7.60 7.47 7.35 7.20 7.13 7.17 — — —
Intuitive Surgical Inc. 2.76 2.85 3.00 3.36 3.52 3.74 3.91 4.12 4.59 4.78 5.02 4.99 5.10 5.12 5.31 5.60 5.90 — — —
Medtronic PLC 5.99 6.52 6.50 6.51 6.54 6.65 6.70 6.62 6.51 6.58 6.67 6.82 6.81 5.94 5.93 5.97 5.96 6.16 5.55 4.98
Stryker Corp. 5.21 5.62 5.57 5.74 5.80 5.91 5.95 6.04 5.94 6.10 6.21 6.20 6.30 6.55 6.80 7.12 7.22 — — —
Thermo Fisher Scientific Inc. 5.45 5.50 5.37 5.42 5.38 5.71 5.66 5.88 5.85 6.01 5.84 5.42 5.17 5.04 7.39 7.31 7.09 — — —
UnitedHealth Group Inc. — 30.80 30.30 29.91 27.60 27.98 26.97 27.93 26.59 27.18 26.87 25.36 28.54 29.82 30.31 29.73 31.18 32.61 33.80 33.19

Based on: 10-K (filing date: 2021-02-12), 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29).

1 Q4 2020 Calculation
Net fixed asset turnover = (Net salesQ4 2020 + Net salesQ3 2020 + Net salesQ2 2020 + Net salesQ1 2020) ÷ Property, plant, and equipment, net
= (1,191,700 + 1,140,900 + 925,000 + 1,128,700) ÷ 1,395,200 = 3.14

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Edwards Lifesciences Corp.’s net fixed asset turnover ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

Edwards Lifesciences Corp., net fixed asset turnover (including operating lease, right-of-use asset) calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Selected Financial Data (US$ in thousands)
Net sales 1,191,700  1,140,900  925,000  1,128,700  1,174,100  1,094,000  1,086,900  993,000  977,700  906,600  943,700  894,800  888,500  821,500  841,800  883,500  767,700  739,400  759,300  697,300 
 
Property, plant, and equipment, net 1,395,200  1,276,300  1,195,600  1,100,600  1,060,300  973,600  931,100  892,200  867,500  826,100  770,200  711,600  679,700  649,600  627,900  588,800  580,000  543,700  516,200  497,300 
Operating lease right-of-use assets 94,200  89,500  84,700  75,500  80,100  73,300  71,200  69,900  —  —  —  —  —  —  —  —  —  —  —  — 
Property, plant, and equipment, net (including operating lease, right-of-use asset) 1,489,400  1,365,800  1,280,300  1,176,100  1,140,400  1,046,900  1,002,300  962,100  867,500  826,100  770,200  711,600  679,700  649,600  627,900  588,800  580,000  543,700  516,200  497,300 
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1 2.95 3.20 3.38 3.81 3.81 3.97 3.96 3.97 4.29 4.40 4.61 4.84 5.05 5.10 5.15 5.35 5.11 — — —

Based on: 10-K (filing date: 2021-02-12), 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29).

1 Q4 2020 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = (Net salesQ4 2020 + Net salesQ3 2020 + Net salesQ2 2020 + Net salesQ1 2020) ÷ Property, plant, and equipment, net (including operating lease, right-of-use asset)
= (1,191,700 + 1,140,900 + 925,000 + 1,128,700) ÷ 1,489,400 = 2.95

Long-term activity ratio Description The company
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). Edwards Lifesciences Corp.’s net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Total Asset Turnover

Edwards Lifesciences Corp., total asset turnover calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Selected Financial Data (US$ in thousands)
Net sales 1,191,700  1,140,900  925,000  1,128,700  1,174,100  1,094,000  1,086,900  993,000  977,700  906,600  943,700  894,800  888,500  821,500  841,800  883,500  767,700  739,400  759,300  697,300 
Total assets 7,237,100  6,800,800  6,424,100  6,076,100  6,488,100  5,966,300  5,573,500  5,469,300  5,323,700  5,958,200  5,686,100  5,825,100  5,695,800  5,488,400  5,138,500  4,780,400  4,510,000  4,339,000  4,051,400  3,853,800 
Long-term Activity Ratio
Total asset turnover1 0.61 0.64 0.67 0.74 0.67 0.70 0.71 0.70 0.70 0.61 0.62 0.59 0.60 0.60 0.63 0.66 0.66 — — —
Benchmarks
Total Asset Turnover, Competitors2
Becton, Dickinson & Co. 0.32 0.31 0.33 0.33 0.33 0.33 0.32 0.32 0.30 0.27 0.25 0.22 0.32 0.33 0.51 0.51 0.49 0.47 0.47 0.43
Boston Scientific Corp. — 0.33 0.33 0.36 0.35 0.39 0.41 0.42 0.47 0.47 0.48 0.48 0.48 0.47 0.47 0.48 0.46 0.46 0.45 0.43
Danaher Corp. 0.29 0.28 0.27 0.26 0.29 0.30 0.35 0.38 0.42 0.41 0.40 0.40 0.39 0.39 0.38 0.38 0.37 — — —
Intuitive Surgical Inc. 0.39 0.41 0.43 0.47 0.46 0.47 0.47 0.47 0.47 0.49 0.50 0.51 0.54 0.53 0.55 0.58 0.42 — — —
Medtronic PLC 0.32 0.33 0.34 0.34 0.34 0.34 0.34 0.33 0.33 0.31 0.31 0.30 0.30 0.30 0.29 0.29 0.29 0.28 0.25 0.22
Stryker Corp. 0.42 0.44 0.45 0.51 0.49 0.55 0.54 0.53 0.50 0.60 0.60 0.58 0.56 0.56 0.56 0.57 0.55 — — —
Thermo Fisher Scientific Inc. 0.47 0.44 0.43 0.44 0.44 0.44 0.43 0.44 0.43 0.43 0.42 0.39 0.37 0.35 0.41 0.41 0.40 — — —
UnitedHealth Group Inc. — 1.31 1.28 1.29 1.38 1.37 1.40 1.43 1.48 1.45 1.37 1.33 1.44 1.39 1.39 1.37 1.50 1.46 1.47 1.40

Based on: 10-K (filing date: 2021-02-12), 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29).

1 Q4 2020 Calculation
Total asset turnover = (Net salesQ4 2020 + Net salesQ3 2020 + Net salesQ2 2020 + Net salesQ1 2020) ÷ Total assets
= (1,191,700 + 1,140,900 + 925,000 + 1,128,700) ÷ 7,237,100 = 0.61

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Edwards Lifesciences Corp.’s total asset turnover ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Equity Turnover

Edwards Lifesciences Corp., equity turnover calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016
Selected Financial Data (US$ in thousands)
Net sales 1,191,700  1,140,900  925,000  1,128,700  1,174,100  1,094,000  1,086,900  993,000  977,700  906,600  943,700  894,800  888,500  821,500  841,800  883,500  767,700  739,400  759,300  697,300 
Stockholders’ equity 4,574,300  4,210,300  3,839,100  3,901,100  4,148,300  3,814,800  3,500,300  3,447,500  3,140,400  3,361,300  3,164,200  3,245,700  2,956,200  3,162,500  2,939,600  2,742,700  2,619,000  2,691,800  2,471,200  2,299,300 
Long-term Activity Ratio
Equity turnover1 0.96 1.04 1.13 1.15 1.05 1.09 1.13 1.11 1.19 1.08 1.12 1.06 1.16 1.05 1.10 1.15 1.13 — — —
Benchmarks
Equity Turnover, Competitors2
Becton, Dickinson & Co. 0.72 0.70 0.83 0.82 0.82 0.80 0.80 0.80 0.76 0.69 0.64 0.58 0.93 0.97 1.55 1.64 1.64 1.53 1.60 1.55
Boston Scientific Corp. — 0.65 0.65 0.78 0.77 1.07 1.07 1.08 1.13 1.17 1.23 1.32 1.29 1.16 1.20 1.22 1.25 1.26 1.28 1.19
Danaher Corp. 0.56 0.54 0.52 0.58 0.59 0.57 0.59 0.62 0.71 0.71 0.71 0.69 0.70 0.70 0.71 0.72 0.73 — — —
Intuitive Surgical Inc. 0.45 0.47 0.50 0.54 0.54 0.55 0.56 0.55 0.56 0.57 0.59 0.60 0.66 0.60 0.63 0.67 0.47 — — —
Medtronic PLC 0.57 0.60 0.61 0.61 0.61 0.61 0.61 0.60 0.59 0.59 0.58 0.59 0.59 0.59 0.58 0.57 0.55 0.56 0.50 0.44
Stryker Corp. 1.10 1.10 1.10 1.14 1.16 1.18 1.19 1.19 1.16 1.35 1.38 1.38 1.25 1.16 1.19 1.21 1.19 — — —
Thermo Fisher Scientific Inc. 0.93 0.90 0.88 0.90 0.86 0.86 0.87 0.89 0.88 0.89 0.87 0.84 0.82 0.80 0.86 0.86 0.85 — — —
UnitedHealth Group Inc. — 3.85 3.87 4.29 4.17 4.33 4.41 4.44 4.35 4.37 4.40 4.34 4.19 4.32 4.44 4.49 4.81 4.78 4.82 4.70

Based on: 10-K (filing date: 2021-02-12), 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29).

1 Q4 2020 Calculation
Equity turnover = (Net salesQ4 2020 + Net salesQ3 2020 + Net salesQ2 2020 + Net salesQ1 2020) ÷ Stockholders’ equity
= (1,191,700 + 1,140,900 + 925,000 + 1,128,700) ÷ 4,574,300 = 0.96

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Edwards Lifesciences Corp.’s equity turnover ratio deteriorated from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.